Alternatives to C2i Genomics
C2i Genomics is a Healthcare tool: comprehensive whole-genome monitoring for cancer recurrence and progression. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to C2i Genomics
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
BiotechMedTechUpdated 28 Sept 2026
NateraNot ratedNatera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.
HealthTechMedTechUpdated 28 Sept 2026
NucleixNot ratedNucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
HealthcareLungUpdated 30 Aug 2026
SenseeraNot ratedDeveloping a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.
HealthcareBloodUpdated 22 Sept 2026
GeneSortNot ratedA molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.
HealthcareNext Generation SequencingUpdated 26 Jul 2026
ImageneNot ratedAI-powered platform for profiling cancer biomarkers from digitized biopsy images.
HealthcareGenomicsUpdated 28 Aug 2026
MeMedNot ratedMeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
HealthcareBloodUpdated 26 Jun 2026
Insitro3.0 out of 5 (1)Data-driven drug discovery and development company using machine learning and high-throughput biology.
HealthcareDrug DiscoveryUpdated 30 Sept 2026
OncohostNot ratedLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
HealthcarePharmaceuticalsUpdated 1 Jul 2026
Bloods AINot ratedAI-powered blood analysis for precise substance tracing and classification in healthcare and research.
HealthcareBloodUpdated 25 Jul 2026
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
BiotechnologyHealthcareUpdated 22 Sept 2026
Diagnostics.aiNot ratedProvides AI-powered data analysis solutions for molecular diagnostics and research, streamlining qPCR data interpretation.
HealthcareDiagnosticsUpdated 26 Jul 2026
AIDGenomicsNot ratedAdvanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.
HealthcarePersonalizedUpdated 26 Jul 2026
JaxBioNot ratedAI-powered blood test for early cancer detection and subtyping.
Life SciencesBiotechUpdated 14 Jul 2026
Moonlight AINot ratedAI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.
HealthTechBiotechnologyUpdated 27 Jun 2026
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
HealthcareImmunologyUpdated 26 Sept 2026
DPEEXNot ratedAI-powered multi-omics platform for early breast cancer detection and risk prediction.
HealthcareCancerUpdated 26 Sept 2026
Nucleai3.0 out of 5 (1)AI-powered spatial biology platform for precision medicine and drug development.
HealthcareOncologyUpdated 6 Sept 2026
VariantyxNot ratedVariantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
HealthcareGenomicsUpdated 26 Jun 2026
Genoox3.0 out of 5 (1)Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
HealthcareGenomicsUpdated 9 Aug 2026
Showing the 20 closest matches. See the rest on the C2i Genomics profile.